NE
Highly rated in
32
conditions
Highly rated in
32
conditions
Check Dr. Nicholette L. Erickson's experience treating your condition:
About Dr. Nicholette L. Erickson

Nicholette Erickson is an Oncologist and a Hematologist Oncology expert in Lewiston, Maine. Erickson has been practicing medicine for over 40 years and is highly rated in 32 conditions, according to our data. Her top areas of expertise are Polycythemia Vera, Breast Cancer, Paget Disease of the Breast, and Lynch Syndrome. She is licensed to treat patients in Maine. Erickson is currently accepting new patients.

Her participating in 9 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Nicholette L. Erickson it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Nicholette L. Erickson accepts the following insurance:

  •  Anthem

Call to see if your plan is accepted.
Locations
17 High St, Lewiston, ME 04240
Other Locations
420 Franklin St, Rumford, ME 04276
Background & Education
Graduate Institution
Virginia Commonwealth University, School Of Medicine, 1982
Specialties
Oncology
Hematology Oncology
Hematology
Licenses
Internal Medicine in ME
Hospital Affiliations
Bridgton Hospital
MaineGeneral Medical Center - Alfond Center For Health
Central Maine Medical Center
Rumford Hospital
St Marys Health System
Franklin Memorial Hospital
Stephens Memorial Hospital
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Development and Implementation of The Breast Cancer Collaborative Registry (BCCR)
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
View 7 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors